908 Devices’ MX908 out-designs designer drugs, unlocks detection capabilities for more than 2000 fentanyl variants

10.08.18 908 Devices, a pioneer of purpose-built analytical devices for chemical and biomolecular analysis, today announced the addition of a novel predictive fentanyl classifier for their MX908 multi-mission trace chemical detection device. The company will preview this new capability with law enforcement at the International Association of Chiefs of Police (IACP) 2018 conference in Orlando. Identification... Read more

FLIR Systems Receives Award Totaling $28.7M for the Next Generation Chemical Detector (NGCD) from the United States Army

WILSONVILLE, Ore. – October 1, 2018 – FLIR Systems, Inc. (NASDAQ: FLIR) announced today it has received an award from the United States Department of Defense (DOD) Joint Program Executive Office for Chemical Biological Radiological and Nuclear Defense (JPEO-CBRND) in support of the Multi-Phase Chemical Agent Detector (MPCAD) program. The Other Transaction Authority Agreement (OTA) is... Read more

PharmaFluidics Facilitates Ultra-high-resolution Proteomics Analysis Through Agreement with Thermo Fisher Scientific

PharmaFluidics NV, an innovative bio-analytical chromatography company, announced today that it entered into a Partnership Agreement with Thermo Fisher Scientific Inc, a global Life Sciences Tools and Instruments leader. The agreement empowers PharmaFluidics to sell Thermo Fisher custom-made EASY-Spray™ transfer lines, in combo sets with PharmaFluidics’ own line of µPAC™ chromatography micro-Chips, to constitute an... Read more

PerkinElmer Receives FDA Clearance for NeoBase™ 2 Non-Derivatized Tandem Mass Spectrometry Kit

In vitro diagnostic solution tests newborn babies for a variety of metabolic disorders with a single dried blood spot card WHAT: PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that its NeoBase™ 2 Non-Derivatized MSMS Kit has received 510(k) clearance from the U.S. Food & Drug Administration (FDA). Used with... Read more

Thermo Fisher Scientific Showcases Innovations in Proteomic Research at HUPO 2018

Thermo Fisher Scientific Showcases Innovations in Proteomic Research at HUPO 2018 ORLANDO, Fla., Oct. 1, 2018 /PRNewswire/ — HUPO 2018 – Demonstrating its commitment to advancing the performance of protein analysis, Thermo Fisher Scientific is showcasing its latest solutions and technologies at the 17th Human Proteome Organization (HUPO) World Congress (booth #401), September 30-October 3 at the... Read more

Bruker Announces Breakthrough Proteomics and Lipidomics Workflow Advances for the timsTOF™ Pro at HUPO 2018

ORLANDO, Fla., Oct. 1, 2018 /PRNewswire/ — At the 17th Annual World Congress of the Human Proteome Organization (www.hupo.org), Bruker announces next-generation workflows for the timsTOF Pro mass spectrometer. Introduced a year ago at the HUPO conference in Dublin, this revolutionary mass spectrometry platform is a new enabling technology for ultra-high sensitivity proteomics and large-cohort clinical... Read more

New Single Quadrupole Mass Spectrometry Technology Designed for Chromatographers Performing LC-MS Routine Analysis

New Single Quadrupole Mass Spectrometry Technology Designed for Chromatographers Performing LC-MS Routine Analysis Thermo Scientific ISQ EM system offers a robust, easy-to-use and reliable solution for both novice and expert users CANNES-MANDELIEU, France, Sept. 24, 2018 /PRNewswire/ — ISC 2018 – Chromatographers looking for bold confidence in their samples can now benefit from a single quadrupole... Read more

Top-Down Analytics Releases a New Report Titled “Liquid Chromatography Survey in China: Chinese Scientists Share Their Preferences”

LOS ANGELES, Sept. 20, 2018 (GLOBE NEWSWIRE) — Top-Down Analytics (TDA), a market research and consulting firm based in Los Angeles, is pleased to announce the release of its latest study titled, “A Liquid Chromatography Survey in China: Chinese Scientists Share Their Preferences” The report is based on a survey of 223 scientists who use... Read more

Waters Corporation Elects Two New Members to its Board of Directors: Linda Baddour and Gary Hendrickson

MILFORD, Mass.–(BUSINESS WIRE)–Sep. 4, 2018– Waters Corporation (NYSE: WAT) today announced that Linda Baddour, former Chief Financial Officer of PRA Health Sciences Inc., and Gary Hendrickson, former Chairman, President and Chief Executive Officer of Valspar Corporation, have been elected as Directors of Waters Corporationeffective September 1, 2018. “I am delighted to welcome both Linda Baddour... Read more